208 related articles for article (PubMed ID: 10449609)
41. The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri.
Nieminen P; Kallio M; Hakama M
Obstet Gynecol; 1995 Jun; 85(6):1017-21. PubMed ID: 7770247
[TBL] [Abstract][Full Text] [Related]
42. Duration of preclinical cervical cancer and reduction in incidence of invasive cancer following negative pap smears.
van Oortmarssen GJ; Habbema JD
Int J Epidemiol; 1995 Apr; 24(2):300-7. PubMed ID: 7635589
[TBL] [Abstract][Full Text] [Related]
43. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
[TBL] [Abstract][Full Text] [Related]
44. Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses.
Barnabas RV; Laukkanen P; Koskela P; Kontula O; Lehtinen M; Garnett GP
PLoS Med; 2006 May; 3(5):e138. PubMed ID: 16573364
[TBL] [Abstract][Full Text] [Related]
45. Cervical cancer screening: A Slovenian experience.
Primic-Zakelj M; Repse-Fokter A
Coll Antropol; 2007 Apr; 31 Suppl 2():23-6. PubMed ID: 17600934
[TBL] [Abstract][Full Text] [Related]
46. [Mass screening for cervical cancer. Experiences after 25 years of voluntary screening and 2 years of organized screening].
Thoresen SO; Skare GB; Sandvin O
Tidsskr Nor Laegeforen; 1997 Aug; 117(18):2613-5. PubMed ID: 9324815
[TBL] [Abstract][Full Text] [Related]
47. Risk of cervical cancer subsequent to a positive screening cytology: follow-up study in Finland.
Viikki M; Pukkala E; Hakama M
Acta Obstet Gynecol Scand; 2000 Jul; 79(7):576-9. PubMed ID: 10929958
[TBL] [Abstract][Full Text] [Related]
48. Age-related incidence of cervical cancer supports two aetiological components: a population-based register study.
Seppä K; Pitkäniemi J; Malila N; Hakama M
BJOG; 2016 Apr; 123(5):772-8. PubMed ID: 26599730
[TBL] [Abstract][Full Text] [Related]
49. Effect of a mass screening program on the risk of cervical cancer.
Hakama M; Räsänen-Virtanen U
Am J Epidemiol; 1976 May; 103(5):512-7. PubMed ID: 1274953
[TBL] [Abstract][Full Text] [Related]
50. Social differences in sexual behaviour and cervical cancer.
de Sanjosé S; Bosch FX; Muñoz N; Shah K
IARC Sci Publ; 1997; (138):309-17. PubMed ID: 9353671
[TBL] [Abstract][Full Text] [Related]
51. Trends in incidence and mortality rates of squamous cell carcinoma and adenocarcinoma of cervix--worldwide.
Mathew A; George PS
Asian Pac J Cancer Prev; 2009; 10(4):645-50. PubMed ID: 19827887
[TBL] [Abstract][Full Text] [Related]
52. Projections of cervical cancer mortality and incidence in New Zealand: the possible impact of screening.
Cox B; Skegg DC
J Epidemiol Community Health; 1992 Aug; 46(4):373-7. PubMed ID: 1431710
[TBL] [Abstract][Full Text] [Related]
53. Estimating the impact of an organised screening programme on cervical cancer incidence: A 26-year study from northern Italy.
Bucchi L; Baldacchini F; Mancini S; Ravaioli A; Giuliani O; Vattiato R; Falcini F; Giorgi Rossi P; Campari C; Canuti D; Di Felice E; Sassoli de Bianchi P; Ferretti S; Bertozzi N; Biggeri A;
Int J Cancer; 2019 Mar; 144(5):1017-1026. PubMed ID: 30120770
[TBL] [Abstract][Full Text] [Related]
54. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
Nygård M; Daltveit AK; Thoresen SO; Nygård JF
BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
[TBL] [Abstract][Full Text] [Related]
55. Cervical cancer screening. Past success and future challenge.
Dewar MA; Hall K; Perchalski J
Prim Care; 1992 Sep; 19(3):589-606. PubMed ID: 1410065
[TBL] [Abstract][Full Text] [Related]
56. Selective screening for cervical cancer. Experience of the Finnish mass screening system.
Hakama M; Pukkala E
Br J Prev Soc Med; 1977 Dec; 31(4):238-44. PubMed ID: 597677
[TBL] [Abstract][Full Text] [Related]
57. [In situ and invasive cervical cancer epidemiology in the province of Girona, Spain 1990-2004: incidence, mortality, survival and screening history].
Castro Marqueta P; Moreno-Crespi J; Buxó-Pujolràs M; Cervantes-Amat M; Pérez-Gómez B; Marcos-Gragera R
Med Clin (Barc); 2011 Feb; 136(5):192-8. PubMed ID: 21051058
[TBL] [Abstract][Full Text] [Related]
58. Organization and results of cervical cancer screening in the German Democratic Republic.
Ebeling K; Nischan P
IARC Sci Publ; 1986; (76):251-66. PubMed ID: 3570410
[TBL] [Abstract][Full Text] [Related]
59. Quality assurance in cervical cancer screening: the Icelandic experience 1964-1993.
Sigurdsson K
Eur J Cancer; 1995; 31A(5):728-34. PubMed ID: 7640046
[TBL] [Abstract][Full Text] [Related]
60. Prevalence, incidence, and estimated life-time risk of cervical human papillomavirus infections in a nonselected Finnish female population.
Syrjänen K; Hakama M; Saarikoski S; Väyrynen M; Yliskoski M; Syrjänen S; Kataja V; Castrén O
Sex Transm Dis; 1990; 17(1):15-9. PubMed ID: 2154865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
